(Q52894914)
Statements
Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure. (English)
Mihai Gheorghiade
1 reference
Gerasimos Filippatos
1 reference
Jayne Middlebrooks
Prasad Turlapaty
Dmitri Kazei
RENO-DEFEND Investigators
1 June 2011
161
6
1012-23.e3